Equities

Bionano Genomics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BNGO:NAQ

Bionano Genomics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.10
  • Today's Change0.000 / 0.00%
  • Shares traded101.75k
  • 1 Year change-80.90%
  • Beta1.6876
Data delayed at least 15 minutes, as of Feb 17 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

  • Revenue in USD (TTM)28.72m
  • Net income in USD-38.59m
  • Incorporated2003
  • Employees98.00
  • Location
    Bionano Genomics Inc9540 Towne Centre Drive, Suite 100SAN DIEGO 92121United StatesUSA
  • Phone+1 (858) 888-7600
  • Fax+1 (858) 888-7601
  • Websitehttps://bionano.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tenon Medical Inc3.23m-12.81m8.65m27.00--3.99--2.68-2.76-2.760.57250.55760.27631.562.96119,740.70-109.47-174.04-149.09-976.4552.4034.39-396.26-788.171.70--0.00--11.92127.6112.25------
SeaStar Medical Holding Corp881.00k-13.67m8.72m19.00--0.7198--9.90-16.43-16.430.68743.360.0876--6.1046,368.42-135.86---290.37--95.35---1,551.08--3.64--0.00------5.34------
ALR Technologies SG Ltd9.49k-8.00m9.12m6.00------960.72-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
HeartSciences Inc8.67k-9.04m9.38m15.00--2.17--1,081.40-6.95-6.950.00571.360.00130.0056--578.00-131.22-145.78-202.97-316.2157.9056.93-104,225.80-42,610.782.00-10.000.1068---76.61-41.63-32.70--21.46--
Movano Inc500.00k-17.05m9.56m32.00------19.12-6.54-6.540.0883-2.040.04850.82163.5115,625.00-165.32-159.40-360.23-208.33-270.20---3,409.60-11,662.690.3451-12.462.32------18.97---9.25--
BioRegenx Inc1.93m-18.93m10.00m5.00------5.19-0.0195-0.01950.002-0.00380.20833.1547.03385,874.00-204.29---341.72--78.14---980.96--0.0416-8.01-----31.40---540.38------
PAVmed Inc29.00k-595.00k10.23m39.0027.7528.01--352.60-0.6822-0.68220.00051.550.0009--3.05743.594.17-115.648.14-8,726.29-520.69--4,931.04-3,891.34----0.2111--22.15--148.24--15.12--
QHSLab Inc2.61m-386.75k10.85m4.00------4.15-0.0373-0.03730.1997-0.05421.4926.3812.80653,480.00-22.10-39.97---284.7966.3755.22-14.80-44.620.17140.30381.63--51.31--44.65------
BioNano Genomics Inc28.72m-38.59m11.19m98.00--0.2149--0.3898-737.92-737.929.995.120.34511.455.84293,061.20-46.37-58.31-69.84-72.5345.9718.60-134.36-487.421.82--0.07---14.7924.8951.82--11.02--
REMSleep Holdings Inc12.27k-3.01m11.32m6.00--46.95--922.87-0.0019-0.00190.000010.00020.01930.8251.51---472.04-107.16-671.87-177.2194.87---24,509.54-1,456.221.73--0.2146---42.47--39.36--5.18--
Beyond Air Inc6.92m-31.00m11.37m61.00--1.12--1.64-5.43-5.431.130.96510.19533.287.74113,508.20-90.33-81.28-107.51-103.401.82---462.58-4,167.724.77-13.320.7262--219.6721.6622.60--166.66--
SINTX Technologies Inc1.27m-16.56m11.52m20.00--2.66--9.07-6.93-6.930.58941.130.11211.345.5263,500.00-86.86-51.41-121.23-64.3452.0566.36-775.12-575.951.60-302.730.0143--9.9033.18-33.06--36.24--
Phaos Technlgy Hldngs (Cayman) Limited132.86k-100.00bn12.20m--------91.82-------0.0604------------------------0.3176------------------
Vicarious Surgical Inc0.00-53.59m12.53m123.00--0.7445-----9.04-9.040.002.360.00----0.00-97.47-35.33-109.17-37.33------------0.00------11.04---6.06--
Trinity Biotech PLC (ADR)49.41m-35.91m14.13m401.00------0.286-2.19-2.223.19-2.570.50941.523.48123,217.00-37.02-23.08-52.54-35.9733.8138.51-72.67-32.840.4083-1.731.79--8.31-7.4115.33---3.22--
Data as of Feb 17 2026. Currency figures normalised to Bionano Genomics Inc's reporting currency: US Dollar USD

Institutional shareholders

13.21%Per cent of shares held by top holders
HolderShares% Held
Iroquois Capital Management LLCas of 30 Sep 2025509.66k5.01%
GSA Capital Partners LLPas of 31 Dec 2025337.78k3.32%
DRW Securities LLCas of 31 Dec 2025168.45k1.66%
Abante Asesores Gesti�n SGIIC SAas of 31 Dec 202595.70k0.94%
Geode Capital Management LLCas of 31 Dec 202566.77k0.66%
Vanguard Fiduciary Trust Co.as of 31 Dec 202551.58k0.51%
Renaissance Technologies LLCas of 31 Dec 202537.00k0.36%
The Vanguard Group, Inc.as of 31 Dec 202530.56k0.30%
Carret Asset Management LLCas of 30 Sep 202525.00k0.25%
Jane Street Capital LLCas of 31 Dec 202522.17k0.22%
More ▼
Data from 30 Sep 2025 - 11 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.